Proscia Forms New Alliance To Help Laboratories Accelerate Scaled Adoption Of Digital Pathology With Confidence

Proscia Ready advances increasingly comprehensive approach for realizing the full promise of digitization

PHILADELPHIA – February 20, 2024 –Proscia^®, a leading provider of digital and computational pathology solutions, has established a new partner alliance to help laboratories grow their use of digital pathology through an increasingly comprehensive approach. Proscia Ready is made up of solution providers committed to delivering more than tightly integrated technologies so that life sciences organizations, including pharmaceutical companies and contract research organizations (CROs), and diagnostic laboratories can realize the full promise of digital pathology today and in the future.

As laboratories expand their digital pathology practices beyond basic image viewing and deploy artificial intelligence (AI), they must implement the right hardware and software solutions to meet their specific goals. These technologies, when successfully integrated in routine practice, can drive efficiencies, improve confidence, and unlock new insights. Even still, the need for multiple solutions can leave laboratories feeling hampered in their ability to scale. They may face a lack of certainty in their selections, limited investment protection, and the increased overhead of working with several vendors.

“It is clear that interoperability is critical to achieving the scaled adoption of digital pathology,” said Imogen Fitt, Senior Market Analyst at Signify Research. “Just as we’ve seen from earlier digitization efforts in healthcare, it is often not enough for partners to solely focus on delivering integrated solutions. Laboratories will increasingly require a more comprehensive approach to make the most of their technology. Proscia Ready is a great example of an initiative intended to address this, and we look forward to seeing its impact in the future.”

Proscia Ready introduces a comprehensive approach that makes it easy for organizations to undergo the initial transition from microscope to whole slide image and work towards 100% digitization by providing:

• Freedom to choose from established technology solutions: Proscia’s Concentriq^® enterprise pathology platform is designed to integrate with partners’ whole slide scanners, image analysis and AI applications, laboratory information systems, and cloud infrastructure, giving laboratories flexibility to select the solutions they need and incorporate them into routine workflows. An open platform, Concentriq also safeguards laboratories’ investments as goals evolve and new innovations expand the value of digital pathology.
• Joint support agreements enabling faster issue resolution: The alliance’s strong working relationship simplifies the support experience, eliminating the need for laboratories to play an active role in resolving issues when they arise. Through close collaboration, the Proscia Ready partners accelerate time-to-resolution as well as streamline implementation, onboarding, and training to help laboratories make the most of their investments.
• A shared vision for capitalizing on innovation: Proscia Ready’s commitment to interoperability extends beyond solutions available today. The community of partners regularly engages to share product roadmaps and best practices to maximize the collective benefits of their solutions and ensure that laboratories can continue to seamlessly incorporate new offerings into their routine operations when the time is right.

“Proscia Ready gives us the confidence we need to consistently exceed our expectations,” said Derek C. Welch, M.D., Chief Medical Officer and Executive Vice-President at PathGroup and Proscia customer. “The alliance makes it easy for us to continue leveraging the latest technologies across our end-to-end workflow while giving us the streamlined experience that comes from working with one vendor. In turn, we can fully empower our pathologists in their day-to-day work.”

Proscia’s CEO David West added, “We have long believed that pathology deserves great technology. The formation of Proscia Ready demonstrates that this is a shared belief guiding key players in our industry. We are excited to join forces with these solution providers to help laboratories increasingly benefit from the innovation that will deliver on digital pathology’s full potential.”

Digital pathology solution providers interested in joining Proscia Ready can learn more here.

About Proscia

Proscia is a software company accelerating the transformation to digital pathology to change the way we understand diseases like cancer. Its Concentriq enterprise pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate R&D, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and 14 of the top 20 pharmaceutical companies rely on Proscia’s software each day. For more information, visit proscia.com.

SOURCE: Proscia